DRAP allows clinical trials of Coronavirus treatment through blood plasma therapy
Drug Regulatory Authority of Pakistan (DRAP) has allowed clinical trials of blood plasma therapy to treat coronavirus patients in the country. Plasma, the fluid in blood teeming with antibodies post-illness,…
